Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
08 November 2022
Closing Date:
07 December 2022
Location(s):
DE DEUTSCHLAND (DE Germany/DEUTSCHLAND)
Description:
46. Generic tender FL

Conclusion of drug discount agreements according to § 130a paragraph 8 of the German Civil Code V

A10BD07 - metformin and sitagliptin

metformin hydrochloride and sitagliptin; 3 Supplements

C07AB02 - Metoprolol

Metoprolol succinate; 3 Supplements

C09DB02 - Olmesartan medoxomil and amlodipine

Olmesartan medoxomil and amlodipine; 3 Supplements

C10AB02 - Bezafibrat

Bezafibrate; 1 surcharge

C10AB02 - Bezafibrat

Bezafibrate; 1 surcharge

D10AF51 - Clindamycin, Combinations

clindamycin and benozyl peroxide; 1 surcharge

G03AC09 - Desogestrel

Desogestrel; 1 surcharge

G04BD07 - Tolterodin

tolterodine (R,R) tartrate; 1 surcharge

H05BX01 - Cinacalcet

cinacalcet; 3 Supplements

H05BX02 - Paricalcitol

paricalcitol; 1 surcharge

J01AA08 - Minocyclin

minocycline; 1 surcharge

A10BH01 - Sitagliptin

sitagliptin; 3 Supplements

J01DH02 - Meropenem

Meropenem; 1 surcharge

J01FA10 - Azithromycin

azithromycin; 1 surcharge

J05AE03 - Ritonavir

ritonavir; 1 surcharge

J05AR06 - Emtricitabine, tenofovir disoproxil and efavirenz

emtricitabine, tenofovir disoproxil and efavirenz; 3 Supplements

M01AE01 - Ibuprofen

Ibuprofen; 1 surcharge

N02AB03 - Fentanyl

fentanyl; 1 surcharge

N04BA02 - Levodopa and decarboxylase inhibitors

levodopa and benserazide; 1 surcharge

N04BA02 - Levodopa and decarboxylase inhibitors

levodopa and benserazide; 1 surcharge

N04BB01 - Amantadin

amantadine hemisulfate; 1 surcharge

N04BC07 - Apomorphin

apomorphine hydrochloride-0.5-water; 1 surcharge

A10BH01 - Sitagliptin

sitagliptin; 1 surcharge

N05AX13 - Paliperidon

paliperidone; 1 surcharge

N05BB01 - Hydroxyzin

hydroxyzine dihydrochloride; 1 surcharge

N05CH01 - Melatonin

Melatonin; 1 surcharge

N06AB10 - Escitalopram

escitalopram; 1 surcharge

N06AB10 - Escitalopram

escitalopram; 1 surcharge

N07XX02 - Riluzol

riluzole; 1 surcharge

P01AX06 - Atovaquon

Atovaquone ; 1 surcharge

R03BA02 – Budesonide

budesonide; 1 surcharge

R03BA05 - Fluticason

fluticasone 17-propionate; 1 surcharge

R03BA05 - Fluticason

fluticasone 17-propionate; 1 surcharge

A11CC55 - Colecalciferol Combinations

colecalciferol and fluoride ions; 1 surcharge

R03DX07 - Roflumilast

roflumilast; 3 Supplements

R05DA04 - Codeine

codeine phosphate-0,5-water; 1 surcharge

S01AE01 - Ofloxacin

Ofloxacin; 1 surcharge

S01AE01 - Ofloxacin

Ofloxacin; 1 surcharge

V03AE02 - Sevelamer

Sevelamer carbonate; 3 Supplements

V03AE02 - Sevelamer

Sevelamer hydrochloride; 1 surcharge

B02AA02 - Tranexamsäure

tranexamic acid; 1 surcharge

B02AA02 - Tranexamsäure

tranexamic acid; 1 surcharge

C01CA24 - Epinephrin

Epinephrine; 1 surcharge

C01CA24 - Epinephrin

Epinephrine; 1 surcharge

C03DA04 - Eplerenon

eplerenone; 3 Supplements

Download full details as .pdf
The Buyer:
spectrumK GmbH
CPV Code(s):
33600000 - Pharmaceutical products